a
Displaying items by tag: FDA
February 21, 2013
Smith & Nephew Names Dr. Michael Friedman to Board of Directors
Global medical device company Smith & Nephew named Michael Friedman, MD, as a non-executive director to join the board April 11.
Published in
Spine and Orthopedic Devices and Implants
February 14, 2013
Dr. D. Kevin Lester Performs First US Knee Replacements With NavioPFS
The first three U.S. unicondylar knee replacement surgeries performed with the NavioPFS system took place at Community Regional Medical Center in Fresno, Calif.
Published in
Spine and Orthopedic Devices and Implants
February 12, 2013
11 Spine Devices Receive FDA 510(k) Clearance in January
The Food and Drug Administration granted 11 spine-related device clearances in January.
Published in
Spine and Orthopedic Devices and Implants
February 12, 2013
AxioMed Introduces Freedom Cervical Disc in Europe
AxioMed Spine Corporation introduced its Freedom Cervical Disc in Europe, and the disc has been successfully implanted in Switzerland.
Published in
Spine and Orthopedic Devices and Implants
February 11, 2013
FDA Approves Planmed Verity Extremity Scanner
The FDA has granted 510(k) approval to the Planmed Verity Extremity Scanner.
Published in
Spine and Orthopedic Devices and Implants
February 07, 2013
25 Orthopedic & Spine Devices Receive FDA 510(k) Clearance in January
The Food and Drug Administration granted 25 orthopedic- and spine-related device clearances in January.
Published in
Spine and Orthopedic Devices and Implants
February 07, 2013
7 Things for Spine Surgeons to Know for Thursday
Here are seven things for spinal surgeons to know for February 7, 2013.
Published in
Spine
Community Regional Medical Center in Fresno, Calif., will be the first to use the NavioPFS system for knee replacements, developed by Blue Belt Technologies in Pittsburgh, according to a report by The Business Journal.
Published in
Spine and Orthopedic Devices and Implants
An FDA advisory panel has voted in favor of moving hydrocodone combination products, including Vicodin, Lortab and Norco, into the more restrictive Schedule II category of controlled substances, according to a report by The Clinical Advisor.
Published in
Pain Management
January 24, 2013
Myoscience Focused Cold Therapy Device Receives FDA Clearance
Myoscience in Redwood City, Calif., a medical device company, announced that the newest generation of its patented device technology has received FDA clearance for the treatment of pain.
Published in
Pain Management




